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Gastrointestinal disorders with abdominal pain are associated with central sensitization
and psychopathologies that are often exacerbated by stress. Here we investigated the
impact of colitis induced by dextran sulfate sodium (DSS) and repeated water avoidance
stress (WAS) on spontaneous and nociception-related behavior and molecular signaling
in the mouse brain. DSS increased the mechanical pain sensitivity of the abdominal
skin while both WAS and DSS enhanced the mechanical and thermal pain sensitivity
of the plantar skin. These manifestations of central sensitization were associated with
augmented c-Fos expression in spinal cord, thalamus, hypothalamus, amygdala and
prefrontal cortex. While WAS stimulated phosphorylation of mitogen-activated protein
kinase (MAPK) p42/44, DSS activated another signaling pathway, both of which
converged on c-Fos. The DSS- and WAS-induced hyperalgesia in the abdominal and
plantar skin and c-Fos expression in the brain disappearedwhen themice were subjected
to WAS+DSS treatment. Intrarectal allyl isothiocyanate (AITC) evoked aversive behavior
(freezing, reduction of locomotion and exploration) in association with p42/44 MAPK
and c-Fos activation in spinal cord and brain. These effects were inhibited by morphine,
which attests to their relationship with nociception. DSS and WAS exerted opposite
effects on AITC-evoked p42/44 MAPK and c-Fos activation, which indicates that these
transduction pathways subserve different aspects of visceral pain processing in the
brain. In summary, behavioral perturbations caused by colitis and psychological stress
are associated with distinct alterations in cerebral signaling. These findings provide
novel perspectives on central sensitization and the sensory and emotional processing
of visceral pain stimuli in the brain.
Keywords: cellular signaling, central nervous system, cerebral pain processing, colonic inflammation, emotional
pain responses, intestinal nociception, psychological stress, somatic hypersensitivity
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Introduction
Visceral pain is a symptom of many gastrointestinal disorders
including inflammatory bowel disease and irritable bowel
syndrome (Schirbel et al., 2010; Halpin and Ford, 2012).
Functional gastrointestinal disorders with abdominal pain are
frequently associated with central sensitization (Moshiree et al.,
2006; Stabell et al., 2013) and psychopathologies that often
are triggered or exacerbated by stress (Levy et al., 2006).
These circumstances emphasize that visceral pain processing
need be studied at the cerebral level, if efficacious therapeutics
are to be developed (Mayer et al., 2008; Holschneider et al.,
2011). However, the interaction between external stressors (e.g.,
psychological stress) and internal stressors (e.g., gastrointestinal
inflammation and nociception) in the sensory and emotional
dimensions of visceral pain is insufficiently understood.
The overall goal of the current study was to investigate
the impact of experimental colitis and psychological stress
on spontaneous and nociception-related behavior as well as
molecular signaling in the mouse brain. Repeated water
avoidance stress (WAS) was used as psychological stressor,
since both acute and repeated WAS have been found to
affect pain sensitivity in rodents (Bradesi et al., 2005; Schwetz
et al., 2005). To study the interaction of WAS with an
internal gastrointestinal stressor, we employed colitis induced
by dextran sulfate sodium (DSS) (Dothel et al., 2013) which
reproduces several pathophysiological features of inflammatory
bowel disease, particularly ulcerative colitis (Sainathan et al.,
2008; Perse and Cerar, 2012).
The first aim was to examine the interaction of DSS-induced
colitis and WAS in mice with respect to inflammation, disease
severity and behavior (locomotion, exploration, ingestion,
motivation, and self-care). The second aim was to investigate
whether DSS-induced colitis, WAS and combined WAS+DSS
treatment are associated with a change in the mechanical and
thermal pain sensitivity of the abdominal and plantar skin.
Intestinal hyperalgesia is related tomechanical hypersensitivity of
the abdominal skin, and this phenomenon of referred pain can be
used as a measure of intestinal pain (Laird et al., 2001; Eijkelkamp
et al., 2007). We further explored whether the behavioral
alterations evoked by DSS and/orWAS are reflected by activation
of p42/44 mitogen-activated protein kinase (MAPK) and c-
Fos in the central nervous system (CNS). Both stress and
gastrointestinal pain are known to cause cerebral p42/44 MAPK
phosphorylation and expression of c-Fos, effects that have been
linked to neuronal excitation, plasticity, and hypersensitivity
(Michl et al., 2001; Obata and Noguchi, 2004; Obata et al., 2004;
Eijkelkamp et al., 2007; Ji et al., 2009; Cargnello and Roux, 2011).
The third aim was to probe whether the behavioral and
molecular CNS responses to acute colonic pain are affected by
DSS-induced colitis and/or WAS. Colonic pain was provoked
by intrarectal allyl isothiocyanate (AITC), which stimulates
transient receptor potential ankyrin-1 and transient receptor
potential vanilloid-1 channels on nociceptive nerve fibers
(Everaerts et al., 2011; Holzer, 2011). AITC has been reported to
evoke visceral pain behavior as well as p42/44 MAPK and c-Fos
activation in the spinal cord (Laird et al., 2001; Mitrovic et al.,
2010), but its effect on cerebral pain processing under conditions
of colitis and psychological stress has not yet been systematically
explored. We therefore examined whether intrarectal AITC
causes nociception-related behavior (freezing, reduction of
locomotion and exploration) in parallel with activation of p42/44
MAPK and c-Fos in the spinal cord and brain. The fourth aim
was to address the question whether the AITC-evoked behavioral
and molecular CNS responses are alleviated by an analgesic drug
such as morphine, thus confirming the nociceptive nature of
these effects (Mitrovic et al., 2010; Schwartz et al., 2013).
Materials and Methods
Experimental Animals
Male C57BL/6N mice (8weeks old, 20–24 g) were obtained
from Charles River (Sulzfeld, Germany) and habituated to the
laboratory environment for at least 2 weeks. The animals were
housed either one (study 2, see below) or two (study 1, 3, 4,
5, and 6, see below) per cage under controlled conditions of
temperature (set point 21◦C), air humidity (set point 50%) and a
12 h light/dark cycle (lights on at 6:00 a.m., lights off at 6:00 p.m.).
Standard laboratory chow (altromin 1324 FORTI, Altromin,
Lage, Germany) was provided ad libitum throughout the studies.
All experiments were approved by an ethical committee at
the Federal Ministry of Science and Research of the Republic
of Austria (BMWF-66.010/0118-II/3b/2011 and BMWFW-
66.010/0054-WF/II/3b/2014) and conducted according to the
Directives 86/609/EEC and 2010/63/EU of the European
Communities Council. The experiments were designed in such
a way that both the number of animals used and their suffering
was minimized.
Study Design
Six studies (study 1–6, Table 1) were carried out. In each
study except study 6, mice were randomly allocated to four
treatment groups: group I (control; no treatment), group II
(WAS, subjected to intermittent WAS for 7 days), group III
(DSS, treated with DSS for 7 days), and group IV (WAS+DSS,
subjected to intermittent WAS and treated with DSS for 7 days).
Group II animals were challenged with intermittent WAS by
placing them 1 h/day (7 days) on a small platform (6× 3× 3 cm;
length×width× height) in the center of a water-filled tank (50×
32 × 30 cm; length × width × height) (Melgar et al., 2008). The
water level in the tank was kept at 0.5 to 1 cm below the platform.
Group III animals were treated with 2% (w/v) DSS (molecular
weight 36,000–50,000; MP Biomedicals, Illkirch, France) in the
drinking water for 7 days. Group IV animals underwent both the
WAS challenge and DSS treatment for 7 days. The body weight
of the animals was measured on day 1 before the start of any
treatment and on day 8.
After completion of the 7-day treatment period, the animals
were randomly assigned to one of the following studies (Table 1).
In study 1, the animals were euthanized by intraperitoneal (i.p.)
injection of pentobarbital (150mg/kg) on day 8; then spinal cords
and brains were isolated, homogenized and subjected to Western
blot analysis. The expression of p42/44 and phosphorylated
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TABLE 1 | Experimental groups and study plan.
Days 1–7 Day 8 Day 9
Study 1
(40 mice)
Control, WAS,
DSS, WAS+DSS
Western blot analysis
Study 2
(28 mice)
Control, WAS,
DSS, WAS+DSS
Recording of locomotion, exploration,
and ingestion
Study 3
(32 mice)
Control, WAS,
DSS, WAS+DSS
Splash test
Study 4
(46 mice)
Control, WAS,
DSS, WAS+DSS
von Frey test Plantar test
Study 5
(80 mice)
Control, WAS,
DSS, WAS+DSS
Intrarectal AITC instillation followed by
recording of visceral pain behavior
and Western blot analysis
Study 6
(32 mice)
Control Intrarectal AITC instillation in the
absence or presence of morphine
followed by recording of visceral pain
behavior and Western blot analysis
p42/44 (pp42/44) MAPK and c-Fos was evaluated in the
lumbosacral spinal cord and brain.
Study 2 and 3 were carried out to examine behavioral changes
in response to the treatment regimens on day 8. In study 2,
short-term activity (locomotion, exploration, and ingestion) for a
period of 60min was measured with the LabMaster system (TSE
Systems, Bad Homburg, Germany). In study 3, the motivational
and self-care behavior of animals was estimated with the splash
test.
Study 4 was designed to assess somatic pain sensitivity of the
abdominal and plantar region. On day 8, the von Frey hair test
for mechanical pain sensitivity and on day 9 the plantar test for
thermal pain sensitivity were performed.
Study 5 was carried out to examine the effect of intrarectal
administration of AITC (Sigma-Aldrich) on visceral pain
behavior and protein expression in the CNS of all four treatment
groups (group I–IV). The animals received an intrarectal
instillation (0.05ml) of either AITC (2% v/v) in peanut oil
(Sigma-Aldrich) or peanut oil (vehicle control for AITC).
Immediately after AITC instillation, visceral pain behavior was
recorded for 15min. One hour post-AITC instillation, the mice
were sacrificed and tissues collected.
Study 6 was carried out to examine the effect of intrarectal
administration of AITC (Sigma-Aldrich, Vienna, Austria), alone
or in combination with morphine (Gerot-Lannach, Lannach,
Austria) premedication, on visceral pain behavior and protein
expression in the CNS of control mice (group I). The animals
received an intrarectal instillation (0.05ml) of either AITC (2%
v/v) in peanut oil (Sigma-Aldrich) or peanut oil (vehicle control
for AITC). One hour prior to AITC treatment, the mice were
treated with a subcutaneous injection (2ml/kg) of either saline
(0.9% NaCl in water, w/v) or morphine (10mg/kg) in saline.
Immediately after AITC instillation, visceral pain behavior was
recorded for 15min. One hour post-AITC instillation, the mice
were sacrificed and tissues collected.
At the end of each study, the animals were euthanized by
pentobarbital (150mg/kg i.p.), and the severity of colitis was
assessed by recording of a disease activity score. In addition,
colon length (without stretching), weight (after cleaning), and
colonic myeloperoxidase (MPO)mass were estimated. At the end
of study 1, 5, and 6, the spinal cords and brains were isolated,
homogenized, and subjected to Western blot analysis.
Experimental Protocols
Disease Activity Score
Following sacrifice, a disease activity score based on fur
appearance and stool consistency was recorded. Normal and
abnormal fur appearance scored 0 and 1, respectively. Normal,
soft but formed and loose stool scored 0, 1, and 2, respectively,
and the absence of bleeding or the presence of blood traces
or gross bleeding in the perianal region scored 0, 1, and 2,
respectively. The absence or presence of blood in the stool was
evaluated with the Hemdetect R© test (DIPROmed, Weigelsdorf,
Austria) and scored as 0 or 1. The sum of all scores in each
category yielded scores of 0 to 6 (Reichmann et al., 2013).
Colonic Myeloperoxidase Content
Myeloperoxidase mass in the distal colon was quantitated with
a commercially available ELISA kit (Hycult Biotechnology,
Uden, The Netherlands). Tissue samples were prepared
according to the manufacturer’s recommendations. Briefly,
tissues were weighed and homogenized in lysis buffer
(200mM NaCl, 5mM ethylenediaminetetraacetic acid, 10mM
trishydroxy methylaminomethane, 10% (v/v) glycerine, 1mM
phenylmethylsulphonyl fluoride (PMSF, Sigma-Aldrich P7626),
1mg/ml leupeptide, and 28mg/ml aprotinin, pH 7.4) at a
tissue:lysis buffer ratio of 1 mg:0.02ml. Tissue debris was pelleted
by centrifugation (two runs at 6000 × g and 4◦C for 15min).
Supernatants were used for measurement of MPO as marker
for neutrophil infiltration. All standard and sample values were
subtracted with blank control values, and MPO concentrations
were quantitated using a standard curve. The sensitivity of the
assay was 1 ng/ml at an intra- and inter-assay variation of around
10% (Reichmann et al., 2013).
Locomotor and Ingestive Activity
The mice were habituated to the water bottles used in
the LabMaster system for 7 days before starting the 7-day
treatment with WAS, DSS or WAS+DSS. On day 8, the
activity (locomotion, exploration, and ingestion) of the animals
was recorded with the LabMaster system. For this purpose,
the mice were placed singly and without habituation in test
cages (42 × 26.5 × 15 cm, length × width × height) which
were connected to the LabMaster system for the recording
of locomotion, exploration (rearing), feeding and drinking for
60min without interruption (study 2). The LabMaster system
was composed of six recording units consisting of six moveable
cages surrounded by two horizontal infra-red frames and a cage
lid with two weight transducers (Painsipp et al., 2013). Two
frames positioned above each other allowed to record ambulatory
(locomotion) and vertical (rearing, exploration) movements. The
two weight transducers were used to record food and water
Frontiers in Behavioral Neuroscience | www.frontiersin.org 3 July 2015 | Volume 9 | Article 177
Jain et al. Visceral pain processing in brain
intake. The recordings of ingestion were normalized to body
weight.
Splash Test
The splash test was used to assess grooming behavior (Taksande
et al., 2013). On day 8, a 10% (w/v) sucrose solution (0.1
to 0.2ml) in water was sprayed on the dorsal surface of the
mice. Subsequently, the mice were placed in small plexiglass
cages with tiny bedding (study 3). The cages were connected
to the LabMaster system to record locomotion and rearing.
Simultaneously, the behavior of the animals during the first
5min was recorded with a video camera to evaluate grooming
behavior. The video recordings were analyzed by a trained
blinded observer with the VideoMot2 (TSE Systems) event
monitoring module. The time taken to start grooming (either
nose/face or head/body grooming) was measured and considered
as an index of self-care while grooming frequency was used to
assess motivational behavior (Taksande et al., 2013). A decrease
in grooming frequency and an increase in grooming latency is
indicative of low motivational and reduced self-care behavior
(Taksande et al., 2013), respectively.
von Frey Hair Test
On day 8 (study 4), the mechanical pain sensitivity of the
abdominal and plantar region was evaluated with von Frey
filaments (Bioseb, Vitrolles, France) by a modification of the
method of Laird et al. (2001). The mice were habituated in
small compartments on a perforated grid (Dynamic Plantar
Aesthesiometer, Ugo Basile, Comerio, Italy) for 1 h before the
test. Subsequently von Frey filaments were applied to the
abdomen (between diaphragm and genitals) and the plantar side
of the right and the left hind paw. The test was performed by a
trained blinded observer. The individual filaments were tested in
an ascending order covering 0.008, 0.02, 0.04, 0.07, 0.16, 0.4, and
0.6 g forces. Each force was applied 10 times to the abdominal
surface, and 5 times to the right and the left hind paw. The
maximal duration of each force application was 2 s, and the
inter-stimulus interval was 2–3min. Following each challenge,
the withdrawal response was quantified either as 1 (withdrawal
of abdominal wall or paw, licking or retraction of animal) or 0
(no response). All counts in response to an individual filament
were averaged. Withdrawal responses to low forces reflect high
mechanical pain sensitivity.
Plantar Test
On day 9 (study 4), the thermal pain sensitivity of the plantar
region was evaluated with the Hargreaves (plantar) test using
the Ugo Basile Thermal Paw Stimulator (Allen and Yaksh,
2004). Before the plantar test, the mice were habituated in
the small compartments of the Ugo Basile Dynamic Plantar
Aesthesiometer for 1 h before the test. Subsequently, the plantar
side of the right and the left hind paw was exposed to an
infrared source through a glass plate (cut-off time: 15 s). The test
was performed by a trained blinded observer. The withdrawal
response was assessed at three infrared intensities (1, 2, and 3;
low to high intensity). The time taken by the mice to move
their paw from the infrared light beam (withdrawal latency) was
recorded. Each hind paw was subjected to 3 trials at an inter-
stimulus interval of 5min, and the average latency was calculated.
A short latency of the withdrawal response reflects high thermal
pain sensitivity.
Visceral Pain Behavior
Two dimensions of visceral pain behavior were simultaneously
recorded after intrarectal administration of peanut oil or AITC
(study 5 and 6). For this purpose, mice were placed in small
plexiglass cages with tiny bedding. Dimension 1 was assessed by a
modification of the method of Laird et al. (2001). In this test, the
freezing behavior (typically associated with the AITC instillation)
of the animals was recorded for 15min with a video camera, and
evaluated with the VideoMot2 (TSE Systems) event monitoring
module by a blinded observer. Dimension 2 of the visceral pain
behavior was a reduction of locomotion and rearing (Schwartz
et al., 2013), which was recorded with the LabMaster system
(TSE Systems) for 5min. A decrease in locomotion and rearing is
thought to reflect nociception-related behavior (Schwartz et al.,
2013). Since the mice were not habituated to the test cages
it cannot be ruled out that a component of novelty-induced
behavior contributed to the recordings.
Tissue Extraction and Microdissection
After euthanization of the animals, the vertebral column was
dissected from head to tail and cleaned. A 5ml syringe filled
with phosphate-buffered saline (PBS, pH 7.4) was used to flush
the spinal cord from the caudal end of the vertebral column.
The whole spinal cord was excised and the lumbosacral region
was identified (Galan et al., 2003). Following dissection, the
spinal cord was collected in homogenization tubes (Peqlab
micro packaging vials, 2ml, Peqlab Biotechnologie, Erlangen,
Germany) containing 1.4mm zirconium oxide beads (Peqlab
Precellys beads), frozen in liquid nitrogen and stored at−70◦C.
Brains were excised, placed on dry ice and stored at −70◦C.
Before microdissection, the brains were placed in a Microm HM
560 cryostat (Microm, Walldorf, Germany) at−20◦C for 30min.
For microdissection, the brains were placed on a cold plate
at −20◦C (Weinkauf Medizintechnik, Forchheim, Germany),
and the forebrains were cut into 8–10 slices. Subsequently
the prefrontal cortex, hypothalamus, thalamus and amygdala
were microdissected under a stereomicroscope and collected in
homogenization tubes, placed on dry ice and stored at −70◦C
(Brunner et al., 2014).
Western Blot Analysis
The spinal cord and microdissected brain regions were
homogenized in lysis buffer (50mM Tris-HCl pH 8, 150mM
NaCl, 1% (v/v) Triton X-100, 0.5% (v/v) sodium deoxycholate,
and 10mM PMSF) and a Peqlab Precellys 24 homogenizer
(two runs at 6500 rpm for 20 s with a 5min refractory period).
The tissue homogenates were centrifuged (10,000 rpm, 4◦C,
10min) to pellet debris. The protein content was measured
with the BCA protein assay kit (Pierce Biotechnology, Rockford,
IL, USA). Total protein lysates (50µg) were mixed with
8µl of 4xNuPAGE LDS sample buffer and 2µl of NuPAGE
sample reducing agent and heated for 10min at 70◦C. Protein
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samples were subjected to electrophoresis on 4–12% gradient
SDS-PAGE gels. After transfer to nitrocellulose membranes
(45µm; Invitrogen, Lofer, Austria), proteins were visualized
with Ponceau’s solution (Sigma-Aldrich). Then the membranes
were blocked with non-fat milk [5% (w/v) Tris-buffered saline
containing Tween 20] (25◦C, 2 h) (Rauh et al., 2008) and
incubated overnight at 4◦Cwith the following primary antibodies
diluted in bovine serum albumin (5% (w/v) in Tris-buffered
saline containing Tween 20): (i) anti-pp42/44 MAPK (1:1000,
Cell Signaling-9106) and (ii) anti-c-Fos (1:1000, Cell Signaling-
2250). After being washed, the membranes were incubated
with horseradish peroxidase-conjugated goat anti-rabbit IgG
(1:200,000, Biomol-6293, Hamburg, Germany) or goat anti-
mouse IgG (1:100,000, Biomol-8101102). Immunoreactive bands
were visualized with Super Signal West Pico Chemiluminescent
substrate (Thermo Scientific, Vienna, Austria) and developed
with the Bio-Rad ChemiDoc MP Imaging System (Bio-
Rad, Vienna, Austria) (Kitz et al., 2011). For normalization,
membranes were stripped (58.4 g/l NaCl, 7.5 g/l glycine, pH
2.15) and incubated with anti-p42/44 MAPK (1:2000, Santa
Cruz SC-94, Heidelberg, Germany) or anti-glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) antibodies (1:1000, Santa
Cruz SC-25778). Densitometric evaluations of immunoreactive
bands were performed with the Image Lab software volume
module.
Statistics
The IBM SPSS 20 and SigmaPlot 12.5 packages were used to
analyze and plot the results. Before applying any statistics, the
data were checked for normal distribution with the Shapiro-Wilk
test. The results of all experiments were analyzed by considering
DSS treatment as one factor and WAS as the other factor. In
experiments involving more than two treatment groups, two-
way ANOVA or repeated measures ANOVA were used for
statistical analysis, as appropriate. A DSS main factor effect
was referred to by the term “DSS effect” (when combined data
from the DSS and WAS+DSS groups were compared with
combined data from the control andWAS groups). Analogously,
a WAS main factor effect was denoted by “WAS effect” (when
combined data from the WAS and WAS+DSS groups were
compared with combined data from the control andDSS groups).
Interactions between the two factors (two-way ANOVA) or three
factors (repeated measures ANOVA) were considered significant
if p ≤ 0.05. The post-hoc Bonferroni test was employed
to compare differences among the treatment groups. When
repeated measures ANOVA was applied, sphericity assumptions
were checked by Mauchly’s test and, in case of violation of
sphericity, the Greenhouse-Geisser correction was used. After
repeated measures ANOVA, the independent-samples t-test
was used to compare differences between two factors or post-
hoc two-way ANOVA was used to test for differences and
interactions between two factors (WAS and DSS). Comparisons
between two groups were made with the independent-samples
t-test. In case of nonparametric distributions, the Kruskal–
Wallis test was employed, and in post-hoc testing the Mann–
WhitneyU-test. The Bonferroni correction was used for pairwise
comparisons.
Results
DSS-induced Colitis Remained Unaffected by
WAS
In order to study the effect of WAS on colitis induced by
DSS, we examined the severity of colitis in all treatment groups
(I–IV). Treatment of mice with DSS (study 1) induced colitis
as seen in treatment groups III (DSS) and IV (WAS+DSS).
Analysis of colitis-associated parameters did not reveal any
significant interaction between WAS and DSS. Treatment with
DSS (DSS effect p < 0.001) led to body weight loss (Figure 1A),
increased disease activity score (Figure 1B), reduced colon length
(Figure 1C) and increased colon weight (Figure 1D) as well as
colonic MPO mass (Figure 1E). WAS exposure alone did not
alter any of these parameters (Figures 1A–E). The changes of
colitis-associated parameters shown in Figure 1 (study 1) were
representative of those seen in the other studies (study 2–5).
Thus, WAS did not alter colitis induced by DSS.
WAS Exposure and WAS+DSS Treatment
Modified Locomotion and Rearing in a
Differential Manner
In order to examine whether DSS-induced colitis, WAS and
combined WAS+DSS treatment affect spontaneous behavior in
mice, we recorded short-term activity (locomotion, exploration,
and ingestion) for a period of 60min. Analysis of activity-related
parameters (study 2) disclosed a significant interaction between
WAS and DSS in their influence on locomotion and rearing (p <
0.01, Figures 2A,B). Bonferroni’s multiple comparison revealed
that WAS exposure significantly increased locomotion (p < 0.05
vs. control) and rearing (p < 0.01 vs. control), whereas DSS
treatment alone had no effect. In contrast, WAS+DSS treatment
led to a significant decrease in locomotion and rearing (p < 0.001
and p < 0.001 vs. WAS, p < 0.05 and p = 0.061 vs. DSS).
Analysis of the food and water intake did not show any significant
interaction between WAS and DSS (Figures 2C,D). Thus, WAS
increased, whereasWAS+DSS treatment decreased, spontaneous
activity (locomotion and rearing) in mice.
WAS Exposure Improved Self-care and
Motivational Behavior
In order to investigate whether DSS-induced colitis, WAS and
combinedWAS+DSS treatment affect self-care and motivational
behavior, we recorded grooming frequency and latency during
the first 5min after spraying a 10% (w/v) sucrose solution on
the dorsal surface of mice. DSS treatment and WAS exposure
(study 3) affected the animal behavior in the splash test in a
disparate fashion (Figures 3A–D), although statistical analysis
of the data did not show any significant interaction between
WAS and DSS in their influence on locomotion, rearing,
total (face + body) grooming frequency and face grooming
latency. However, locomotion and rearing of DSS-treated mice
in response to spraying of sucrose solution on the dorsal surface
was significantly decreased (DSS effect p < 0.001, Figures 3A,B).
The total grooming frequency was increased in WAS-exposed
mice while the face grooming latency was shortened (WAS effect
p < 0.05, Figures 3C,D). Face grooming typically preceded body
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FIGURE 1 | Effect of a 7-day treatment of mice with DSS, WAS,
and WAS+DSS on colitis-associated parameters measured on day
8 (study 1). Panel (A) shows percentage of body weight change
relative to the weight measured before the treatment started, (B)
disease activity score, (C) colon length, (D) colon weight, and (E)
colonic MPO mass. Values are expressed as means + SEM or - SEM
(n = 8–12). Two-way ANOVA did not show any WAS × DSS interaction
and any WAS effect but revealed a DSS effect (ap < 0.05).
FIGURE 2 | Effect of a 7-day treatment of mice with DSS, WAS, and
WAS+DSS on short-term activity (60min) measured on day 8 (study 2).
Panel (A) shows locomotion, (B) rearing, (C) food intake, and (D) water intake.
Water and food intake are expressed relative to the body weight (BW) of the
animals. Values are expressed as means + SEM (n = 6–8). Two-way ANOVA
revealed a WAS × DSS interaction (p < 0.01), and post-hoc analysis
(Bonferroni’s multiple comparison) demonstrated significant differences:
*p < 0.05 vs. Control; $p < 0.05 vs. WAS; #p < 0.05 vs. DSS.
grooming. Thus, WAS increased both motivational and self-care
behavior of mice in the splash test.
WAS Exposure and DSS Treatment Increased the
Somatic Sensitivity to Mechanical and Thermal
Stimuli
In order to study the effect of DSS-induced colitis, WAS and
combinedWAS+DSS treatment on somatic nociception in mice,
we assessed the sensitivity of the abdominal skin to mechanical
FIGURE 3 | Effect of a 7-day treatment of mice with DSS, WAS, and
WAS+DSS on (A) locomotion, (B) rearing, (C) total (face + body)
grooming frequency, and (D) face grooming latency recorded in the
splash test performed on day 8 (study 3). All parameters were recorded for
5min after spraying the mice with sucrose solution. Values are expressed as
means + SEM (n = 8–12). Two-way ANOVA did not show any WAS × DSS
interaction but revealed a DSS effect (ap < 0.05) and a WAS effect (bp < 0.05).
stimuli and of the plantar skin tomechanical and thermal stimuli.
Assessment of the mechanical sensitivity in the abdominal region
with the von Frey test did not reveal any significant interaction
between WAS/DSS and the test forces in their influence on the
withdrawal response (study 4). There was, however, a significant
interaction between WAS exposure and test forces as well as
between DSS treatment and test forces in their impact on the
withdrawal response (p < 0.05, Figure 4A). To examine these
effects further, post-hoc analysis with the independent-samples
t-test revealed only a DSS effect, as DSS treatment led to a
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FIGURE 4 | Effect of a 7-day treatment of mice with DSS, WAS, and
WAS+DSS on mechanical pain sensitivity of the abdomen (A) and
plantar hind paw region (B) and on thermal pain sensitivity of the
plantar hind paw region (C) recorded with the von Frey test on day 8
and the plantar test on day 9, respectively (study 4). Values are
expressed as means ± SEM or + SEM (n = 10–12). Repeated measures
ANOVA (A) did not show any WAS × DSS × forces interaction in the
withdrawal response from abdominal stimulation but revealed a WAS ×
forces and a DSS × forces interaction (p < 0.05). Post-hoc analysis
(independent-samples t-test) demonstrated a DSS effect (ap < 0.05) as
indicated in (A). Repeated measures ANOVA disclosed a WAS × DSS ×
forces interaction (p < 0.05) in the withdrawal response to mechanical
plantar stimulation (B) and a WAS × DSS × intensity interaction (p < 0.05) in
the withdrawal response to thermal plantar stimulation (C). Post-hoc
(two-way ANOVA) analysis demonstrated a WAS × DSS interaction at the
0.04 g force (p < 0.001) (B) and a WAS effect (bp < 0.05) at infrared intensity
1 (C). Post-hoc (Bonferroni’s multiple comparison) analysis demonstrated
significant differences: *p < 0.05 vs. Control; $p < 0.05 vs. WAS.
significant increase in the withdrawal response to the 0.04 g force
(DSS effect p < 0.05, Figure 4A).
Evaluation of the mechanical sensitivity of the plantar region
with the von Frey test disclosed a significant interaction (p <
0.05, Figure 4B) between WAS/DSS and the test forces in their
effect on the withdrawal response. Two-way ANOVA showed
a significant interaction between WAS and DSS at three test
forces; 0.02 g (p < 0.01), 0.04 g (p < 0.001, and 0.07 g (p <
0.05). Bonferroni’s multiple comparison analysis revealed that the
withdrawal response to forces of 0.02 g (p < 0.01 vs. control) and
0.04 g (p < 0.001 vs. control) was significantly increased inWAS-
exposedmice. In DSS-treated animals the withdrawal response to
forces of 0.02 g (p < 0.001 vs. control) and 0.04 g (p < 0.01 vs.
control) was also significantly enhanced. WAS+DSS treatment
led to a significant decrease in the withdrawal response to forces
of 0.04 g and 0.07 g (p < 0.01 and p = 0.05 vs. WAS) and to
forces of 0.02 g and 0.04 g (p = 0.05 and p = 0.054 vs. DSS)
(Figure 4B).
Assessment of the thermal sensitivity on the plantar side of the
hindpaw with the plantar test showed that there was a significant
interaction (p < 0.05) between the two main factors (WAS and
DSS) and the intensity of the infrared light stimulus (1, 2, and
3) in their impact on withdrawal latency (Figure 4C). While, as
disclosed by post-hoc analysis, there was no effect of intensity 1
(data not shown) on withdrawal latency, WAS exposure caused a
significant decrease in withdrawal latency (WAS effect p < 0.05)
at intensity 2. A significant interaction (p < 0.05) between
WAS and DSS was found at intensity 3. Bonferroni’s multiple
comparison revealed that the withdrawal latency was significantly
decreased in both WAS-exposed and DSS-treated mice (p <
0.001 and p < 0.05 vs. control) (Figure 4C).
These data show that DSS causes mechanical hypersensitivity
of the abdominal skin while both DSS and WAS induce
mechanical and thermal hypersensitivity of the plantar skin.
These effects were absent in animals treated with WAS+DSS.
WAS Exposure and DSS Treatment Induced
Phosphorylation of p42/44 MAPK and c-Fos
Expression in the Spinal Cord
On the molecular level, we examined the effect of DSS-
induced colitis, WAS and combined WAS+DSS treatment
on p42/44 MAPK phosphorylation and c-Fos expression in
Frontiers in Behavioral Neuroscience | www.frontiersin.org 7 July 2015 | Volume 9 | Article 177
Jain et al. Visceral pain processing in brain
the spinal cord. WAS exposure and DSS treatment (study 1)
induced phosphorylation of p42/44 MAPK and c-Fos expression
in the spinal cord (Figures 5A,C). Densitometric evaluation
of the immunoreactive pp42/44 MAPK and c-Fos bands
showed a significant interaction between the WAS and DSS
treatments (p < 0.05, Figures 5B,D). Bonferroni’s multiple
comparison revealed that DSS treatment increased p42/44
MAPK phosphorylation (p < 0.01 vs. control) and c-Fos
expression (p < 0.05 vs. control), while WAS exposure enhanced
only c-Fos expression (p < 0.001 vs. control). WAS+DSS
treatment led to a decrease in pp42/44 MAPK (p < 0.05 vs.
DSS) and c-Fos (p < 0.001 vs. WAS) expression. Thus, DSS, but
not WAS and WAS+DSS, caused MAPK phosphorylation in the
spinal cord while c-Fos expression was stimulated by WAS and
DSS, but not WAS+DSS.
WAS Exposure and DSS Treatment Induced
Phosphorylation of p42/44 MAPK and c-Fos
Expression in the Brain
We further explored the effect of DSS-induced colitis, WAS
and combined WAS+DSS treatment on p42/44 MAPK
phosphorylation and c-Fos expression in the brain. WAS
exposure and DSS treatment induced phosphorylation of p42/44
MAPK and c-Fos expression (study 1) in distinct brain areas
(Figures 5A,C). Densitometric evaluation of the immunoreactive
pp42/44 MAPK bands (thalamus, hypothalamus, amygdala, and
prefrontal cortex) failed to show any significant interaction
between the WAS and DSS treatments. WAS exposure induced
p42/44 MAPK phosphorylation (Figure 5B) in the thalamus
(p < 0.05), hypothalamus (p < 0.01), amygdala (p < 0.001),
and prefrontal cortex (p < 0.01) (WAS effect).
WAS exposure and DSS treatment also induced c-Fos
expression in specific brain areas. Densitometric evaluation of
the immunoreactive c-Fos bands showed a significant interaction
(p < 0.001) between WAS and DSS in the thalamus,
hypothalamus, amygdala, and prefrontal cortex (Figure 5D).
Bonferroni’s multiple comparison revealed that WAS exposure
and DSS treatment increased c-Fos expression in the thalamus,
hypothalamus, amygdala (p < 0.001 vs. control) and prefrontal
cortex (p < 0.01 vs. control). Conversely, WAS+DSS treatment
decreased c-Fos expression (p < 0.001 vs. WAS, p < 0.001 vs.
DSS) in the thalamus, hypothalamus, amygdala, and prefrontal
cortex. Thus, WAS and WAS+DSS, but not DSS, caused
MAPK phosphorylation in the brain while c-Fos expression was
stimulated by WAS and DSS, but not WAS+DSS.
Intrarectal AITC Challenge Induced Freezing and
Reduced Locomotion and Rearing in Control
Mice
The behavioral manifestations of acute visceral pain were studied
following instillation of AITC into the mouse colon. Analysis
of the visceral pain behavior data (dimension 1 and 2, study 5)
demonstrated that intrarectal administration of AITC to control
mice prolonged their freezing behavior (p < 0.01 vs. vehicle,
FIGURE 5 | Effect of a 7-day treatment of mice with DSS, WAS,
and WAS+DSS on protein expression (A/B: phosphorylated
p42/44 (pp42/44)/p42/44 MAPK, C/D: c-Fos/GAPDH) on day 8 in
the spinal cord (Sc), thalamus (Th), hypothalamus (Hth),
amygdala (Amy), and prefrontal cortex (Pfc) (study 1). Panels
(A,C) show representative Western blots and (B,D) show quantitative
data obtained by densitometric evaluation of the Western blots,
expressed as x fold over control. Values shown in (B,D) are
expressed as means + SEM (n = 3–4). Two-way ANOVA showed a
WAS × DSS interaction (p < 0.05) in pp42/44 (B) and c-Fos (D)
expression in the spinal cord, and a WAS × DSS interaction
(p < 0.001) in c-Fos expression in the thalamus, hypothalamus,
amygdala, and prefrontal cortex (D). In addition, a WAS effect
(bp < 0.05) was revealed as depicted in (B). Post-hoc (Bonferroni’s
multiple comparison) analysis demonstrated significant differences:
*p < 0.05 vs. Control; $p < 0.05 vs. WAS; #p < 0.05 vs. DSS.
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FIGURE 6 | Effect of intrarectal instillation of peanut oil (Veh) and
AITC 2% (v/v) to elicit visceral pain behavior in control mice (A–C) and
in mice treated with WAS, DSS, and WAS+DSS for 7 days, relative to
control mice (D–F). The visceral pain behavior (prolonged freezing and
reduced locomotion and rearing) was measured on day 8 (study 5). In
dimension 1, freezing (A,D) was recorded for 15min, and in dimension 2
locomotion (B,E) and rearing (C,F) were recorded for 5min after intrarectal
instillation. Note that the dimension of the y axis scale in (B,E) is ×100.
Values are expressed as means + SEM (n = 8–12). The
independent-samples t-test disclosed a significant difference between Veh
and AITC in (A,B) (+p < 0.01) and (B) (+p < 0.05). Two-way ANOVA did not
show any WAS × DSS interaction but revealed a DSS effect (ap < 0.01) and
a WAS effect (bp = 0.05) with regard to changes in locomotion and rearing
as indicated in (D–F).
Figure 6A) while locomotion (p < 0.01 vs. vehicle, Figure 6B)
and rearing (p < 0.05 vs. vehicle, Figure 6C) were significantly
shortened.
Intrarectal AITC Challenge Reduced Freezing in
DSS-treated Mice and Induced Locomotion and
Rearing in WAS-exposed Mice
In order to examine whether DSS-induced colitis, WAS and
combined WAS+DSS treatment affect visceral nociception in
mice, pain-related behavior was recorded during the first 5min
after intrarectal AITC administration. The visceral pain behavior
evoked by AITC (study 5) was modified by WAS exposure and
DSS treatment in a differential manner, although there was no
significant interaction between WAS and DSS in their influence
on AITC-evoked changes of freezing, locomotion, and rearing
in the treatment groups. The freezing counts were significantly
decreased in DSS-treated mice (DSS effect p < 0.01, Figure 6D)
while locomotion (WAS effect p = 0.05, Figure 6E) and rearing
(WAS effect p = 0.06, Figure 6F) were prolonged in WAS-
exposed mice. Thus, DSS reduced freezing and WAS increased
locomotion in response to intrarectal AITC administration in
mice.
WAS Exposure and DSS Treatment Modified
AITC-evoked Phosphorylation of p42/44 MAPK
and c-Fos Expression in the Spinal Cord and
Brain
In a subsequent experiment we investigated the effect of DSS-
induced colitis, WAS and combined WAS+DSS treatment
on the AITC-induced p42/44 MAPK phosphorylation and
c-Fos expression in the spinal cord and brain. The effect of
intrarectal AITC challenge (study 5) to induce phosphorylation
of p42/44 MAPK and expression of c-Fos in the spinal cord
and brain, as seen in control mice, was altered by DSS,
WAS, and WAS+DSS treatment in a region-related manner
(Figures 7A,C). Densitometric evaluation of the immunoreactive
bands revealed a significant interaction between WAS and
DSS with respect to AITC-evoked levels of pp42/44 MAPK
in the thalamus (p < 0.05), hypothalamus (p < 0.01),
and prefrontal cortex (p < 0.05) (Figure 7B). Bonferroni’s
multiple comparison revealed that the effect of AITC to
enhance p42/44 MAPK phosphorylation in the thalamus (p <
0.01), hypothalamus (p = 0.05), and prefrontal cortex
(p < 0.01) was mitigated in DSS-treated mice (vs. control
mice). This inhibitory effect of DSS treatment on the AITC
response in the brain was reversed by concomitant WAS
exposure (WAS+DSS). When compared to DSS-treated mice,
phosphorylation of p42/44 MAPK was increased in the thalamus
(p = 0.06), hypothalamus (p < 0.05), and prefrontal
cortex (p < 0.01) of WAS+DSS-treated mice (Figure 7B).
There was no significant interaction between WAS and DSS
with regard to the AITC-evoked pp42/44 MAPK expression
in the spinal cord. However, DSS treatment decreased AITC-
evoked pp42/44 MAPK levels in the spinal cord (p <
0.05) (DSS effect). Thus, DSS reduced AITC-evoked MAPK
phosphorylation in the thalamus, hypothalamus, and prefrontal
cortex, an effect that was absent in animals treated with
WAS+DSS.
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FIGURE 7 | Effect of intrarectal instillation of peanut oil (Veh) and
AITC 2% (v/v) on protein expression (A/B: phosphorylated p42/44
(pp42/44)/p42/44 MAPK, C/D: c-Fos/GAPDH) in the spinal cord
(Sc), thalamus (Th), hypothalamus (Hth), amygdala (Amy), and
prefrontal cortex (Pfc) of control (Con) mice and mice treated with
WAS, DSS, and WAS+DSS for 7 days (study 5). Protein expression
was evaluated on day 8. Panels (A,C) show representative Western blots
and (B,D) show quantitative data obtained by densitometric evaluation of
the Western blots, expressed as x fold over control. Values shown in
(B,D) are expressed as means + SEM (n = 3–4). Two-way ANOVA
demonstrated a WAS × DSS interaction in pp42/44 expression (B) in the
thalamus (p < 0.05), hypothalamus (p < 0.05), and prefrontal cortex
(p < 0.05) and in c-Fos expression (D) in the spinal cord (p < 0.01),
thalamus (p < 0.05), hypothalamus (p < 0.001), and amygdala (p < 0.05).
In addition, a DSS effect (ap < 0.05) was revealed as depicted in (B).
Post-hoc (Bonferroni’s multiple comparison) analysis demonstrated
significant differences: *p < 0.05 vs. Control+AITC; $p < 0.05 vs.
WAS+AITC; #p < 0.05 vs. DSS+AITC.
Densitometric evaluation of the immunoreactive c-Fos bands
(Figure 7C) revealed a significant interaction between WAS
and DSS with regard to the AITC-evoked c-Fos expression
in the spinal cord (p < 0.01), thalamus (p < 0.05),
hypothalamus (p < 0.001), and amygdala (p < 0.05)
(Figure 7D). Bonferroni’s multiple comparison showed that the
effect of AITC to stimulate c-Fos expression was decreased in
the thalamus (p < 0.001), but increased in the hypothalamus
(p < 0.05) and amygdala (p < 0.001) of WAS-exposed
animals (vs. control animals). The effect of AITC to induce c-
Fos expression in the thalamus was diminished (p < 0.01)
in DSS-treated animals, but enhanced (p < 0.05) in the
spinal cord (vs. control mice, Figure 7D). The effects of WAS
exposure and DSS treatment on the c-Fos response to AITC
were reversed in the spinal cord and particular brain regions
when the two treatments were combined (Figure 7D). Thus, in
mice treated with WAS+DSS, the AITC-evoked expression of
c-Fos in the spinal cord, thalamus, hypothalamus (p < 0.001)
and amygdala (p < 0.01) was decreased relative to animals
treated with DSS. Moreover, c-Fos expression was diminished
in the spinal cord (p < 0.01), hypothalamus (p < 0.01)
and amygdala (p < 0.001) of mice treated with WAS+DSS
(vs. WAS). Taken together, DSS, WAS and WAS+DSS
treatment altered AITC-evoked expression of c-Fos in the
spinal cord and brain in a treatment- and region-dependent
manner.
Morphine Modified the Effects of AITC on
Freezing, Locomotion, and Rearing in Control
Mice
In order to address the question whether the behavioral and
molecular CNS responses to intrarectal AITC administration are
related to pain, control mice were injected withmorphine prior to
AITC instillation. Morphine had distinct effects on the behavior
of mice (study 6). The freezing counts recorded in morphine-
treated control mice were not normally distributed, and analysis
of the data with a non-parametric test revealed significant
differences in freezing behavior (p < 0.001, Figure 8A) among
the treatment combinations (saline + peanut oil, saline + AITC,
morphine + peanut oil, morphine + AITC) in control animals.
Post-hoc analysis with the Mann–Whitney U-test confirmed
that AITC instillation in saline-injected control mice prolonged
freezing (p < 0.05 vs. saline + peanut oil). Morphine caused
an approximately 50% (although non-significant) reduction of
freezing counts in AITC-treated mice (Figure 8A).
Locomotion and rearing were likewise affected by morphine.
In morphine-injected control mice a 2-fold increase in
locomotion and approximately 10-fold increase in rearing
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FIGURE 8 | Visceral pain behavior (freezing, locomotion and rearing) in
control mice (A–C) following intrarectal instillation of peanut oil (Veh)
or AITC 2% (v/v) in the absence or presence of morphine. Saline or
morphine (10mg/kg, s.c.) was injected 1 h prior to intrarectal instillation. The
visceral pain behavior was measured on day 8 (study 6). In dimension 1,
freezing (A) was recorded for 15min, and in dimension 2 locomotion (B) and
rearing (C) were recorded for 5min after intrarectal instillation. Please note that
the dimension of the y axis scale (B,C) is ×100 and ×10, respectively. Values
are expressed as means + SEM (n = 7–8). Data in (A) were evaluated with the
Kruskal–Wallis one-way ANOVA test (p < 0.001), and the Mann–Whitney
U-test (post-hoc test) demonstrated a significant difference between Veh and
AITC in saline-injected control mice (+p < 0.05).
was observed when compared to saline-injected control mice
(Figures 8B,C). The extensive increase in rearing was most
likely a recording artifact caused by the morphine-evoked
Straub phenomenon (upright position of the tail) (Faenzi,
1961). The behavioral parameters recorded after peanut oil
instillation to saline-injected mice did not significantly differ
from those recorded without prior saline injection (compare
Figure 8 with Figures 6A–C). Taken all findings together, the
effect of morphine on the AITC-evoked pain behavior proved
difficult to evaluate becausemorphine per se increased the activity
of the mice.
Morphine Blunted the AITC-evoked
Phosphorylation of p42/44 MAPK and c-Fos
Expression in the Spinal Cord and Brain of
Control Mice
The AITC-induced levels of both MAPK and c-Fos were
markedly diminished in morphine-injected control animals
(Figures 9A,C). Densitometric evaluation of the immunoreactive
bands confirmed the effect of AITC to increase (p < 0.05 vs.
vehicle) the phosphorylation of p42/44MAPK and the expression
of c-Fos (Figures 9B,D) in the spinal cord and all brain regions
examined. Morphine blunted the AITC-evoked rise of c-Fos
and pp42/44 MAPK levels in the brain and spinal cord in a
region-dependent manner (Figures 9B,D). The expression of c-
Fos and pp42/44 MAPK in the CNS measured after peanut oil
instillation to saline-injected mice did not significantly differ
from that measured without prior saline injection (compare
Figure 9 with Figure 7). Taken all data together, morphine
reduced the effect of intrarectal AITC to evoke freezing, MAPK
phosphorylation and c-Fos expression in the CNS of control
mice.
Discussion
Chronic visceral pain in inflammatory bowel disease and
irritable bowel syndrome can be exaggerated by stress, but
the mechanisms behind this relationship are little understood.
We therefore examined in which way DSS-induced colitis and
repeated WAS, a psychological stressor, interact in shaping
visceral pain-related behavior and molecular signaling in the
CNS. In the interpretation of WAS/DSS interactions it need be
emphasized that WAS failed to alter the severity of DSS-induced
colitis as judged by body weight, colon length, colon weight,
colonic MPO content, and disease activity score (Figures 1A–E).
Although repeated WAS can disturb gastrointestinal function
(Soderholm et al., 2002; Velin et al., 2004), our findings confirm
other reports that WAS does not modify experimental colitis in
rodents (Deiteren et al., 2014; Hassan et al., 2014). We hence
conclude that WAS/DSS interactions with respect to pain-related
behavior and molecular signaling in the CNS do not reflect
WAS-induced alterations of colitis but take place within the
brain.
Colitis and WAS Result in Alterations of
Spontaneous Behavior and CNS Signaling
Inflammation and psychological stress modify behavior related
to emotionality, pain (Cattaruzza et al., 2013; Banozic et al.,
2014) and sickness (Zhang et al., 2014; Farzi et al., 2015).
Increased activity in rats exposed to unpredictable chronic mild
stress resembles the psychomotor agitation seen in patients
with psychiatric disorders (Gronli et al., 2005). Here we
found that WAS increased, whereas WAS+DSS treatment
decreased, spontaneous activity (locomotion and rearing) in
mice (Figures 2A,B). It should be noted that these alterations
of spontaneous behavior included a component of novelty-
induced behavior since the animals were not habituated to the
test cages. The behavioral perturbations occurred independently
of changes in ingestion (Figures 2C,D) and thus do not reflect
sickness but are rather of an emotional-affective nature. Repeated
WAS has been argued to represent a model of predictable
chronic stress (Hassan et al., 2014), which may explain why
WAS increased both motivational and self-care behavior in
the splash test (Figures 3A–D). This beneficial influence of
WAS is consistent with its ability to counteract the effects of
DSS-induced colitis to reduce social interaction and elevate
anxiety in association with increased plasma corticosterone and
hypothalamic neuropeptide Y mRNA expression (Hassan et al.,
2014).
WAS and DSS were also found to alter c-Fos expression and
MAPK phosphorylation in the CNS independently of any acute
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FIGURE 9 | Protein expression (A/B: phosphorylated p42/44
(pp42/44)/p42/44 MAPK, C/D: c-Fos/GAPDH) in the spinal cord
(Sc), thalamus (Th), hypothalamus (Hth), amygdala (Amy), and
prefrontal cortex (Pfc) of control mice following intrarectal
instillation of peanut oil (Veh) or AITC 2% (v/v) in the absence or
presence of morphine (study 6). Saline or morphine (10mg/kg, s.c.)
was injected 1 h prior to intrarectal instillation. Panels (A,C) show
representative Western blots, and (B,D) show quantitative data obtained
by densitometric evaluation of the Western blots, expressed as x fold
over control. Values shown in (B,D) are expressed as means + SEM
(n = 3–4). The graph compares the AITC-induced protein expression
levels in control animals (Veh + Con in Figure 7 pooled with Saline +
Veh in Figure 9) with those in morphine-treated animals (Morphine +
Veh in Figure 9). Values are given as means + SEM (n = 3–6). Analysis
with the independent-samples t-test disclosed significant
differences: +p < 0.05 vs. Saline+Veh; §p < 0.05 vs. Saline+AITC.
intervention (Figures 5A–D). These changes in CNS signaling
are most likely related to the alterations of spontaneous behavior
in WAS-exposed and DSS-treated mice. The induction of c-Fos
occurs downstream of MAPK stimulation but is also regulated by
other signaling pathways (Kovacs, 1998; O’Donnell et al., 2012;
Reul, 2014), which is consistent with the dissimilar MAPK and c-
Fos activation patterns in the different treatment groups. While
both DSS and WAS induced c-Fos in the spinal cord, thalamus,
hypothalamus, amygdala, and prefrontal cortex, cerebral MAPK
phosphorylation was not affected by DSS but enhanced by
WAS. We surmise that p42/44 MAPK activation is of particular
relevance to the emotional and motivational alterations seen in
WAS-exposed mice.
It is worth noting that combined WAS+DSS treatment
induced less c-Fos in the CNS than WAS or DSS separately
(Figures 5C,D). This observation may be related to the finding
that WAS+DSS treatment increases circulating corticosterone
to a larger extent than WAS or DSS alone (Hassan et al.,
2014), given that dexamethasone inhibits c-Fos induction by
stress and inflammatory pain (Buritova et al., 1996; de Medeiros
et al., 2005). Such a mechanism may also apply to the effect
of WAS+DSS to decrease locomotion whereas WAS enhances
this parameter and DSS has no effect (Figure 2A). Since, in
addition, WAS prevents the anxiogenic effect of DSS (Hassan
et al., 2014), we assume that WAS-evoked locomotion reflects
psychomotor agitation which is mirrored by MAPK activation
and c-Fos expression in the CNS.
Central Sensitization Evoked by WAS and Colitis
is Mirrored by Alterations in CNS Signaling
Visceral hypersensitivity to colonic distention develops after
DSS or WAS exposure (Larauche et al., 2011; Chen et al.,
2013; Deiteren et al., 2014), and the present findings show
that DSS causes mechanical hypersensitivity of the abdominal
skin while both DSS and WAS induce mechanical and thermal
hypersensitivity of the plantar skin. This observation is indicative
of somatic hyperalgesia, whereas the DSS-induced mechanical
hyperalgesia of the abdominal skin reflects most likely referred
pain associated with experimental colitis (Laird et al., 2001;
Eijkelkamp et al., 2007) because WAS failed to alter the
mechanical pain sensitivity of the abdomen. The presence
of somatic hyperalgesia in mice with DSS-induced colitis is
consistent with the presence of somatic hyperalgesia in irritable
bowel syndrome patients (Stabell et al., 2013). Since both colitis
and WAS induce visceral and/or somatic pain hypersensitivity,
we conclude that pain sensitization takes place at the CNS level.
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The literature regarding the effect of WAS on visceral pain is
inconsistent. Several reports attest to WAS-induced mechanical
hypersensitivity in male Wistar, Long-Evans and Fischer-344 rats
(Bradesi et al., 2005; Schwetz et al., 2005; Johnson et al., 2015),
although other reports hold that repeated exposure to WAS does
not alter mechanical sensitivity in female Wistar rats (Deiteren
et al., 2014) or even causes immediate post-stress hypoalgesia in
female Wistar rats (Larauche et al., 2012) and male Long-Evans
rats (Schwetz et al., 2005). Our and another study in male and
female mice (Larsson et al., 2009), respectively, failed to observe
any repeated WAS-induced mechanical hypersensitivity, which
could relate to the absence of changes in corticotropin-releasing
factor (CRF) and glucocorticoid receptor mRNA expression in
the mouse amygdala (Hassan et al., 2014). In male Fischer-
344 rats, however, both CRF and glucocorticoid signaling in
this region contribute to visceral hypersensitivity (Myers and
Greenwood-Van Meerveld, 2012; Johnson et al., 2015). Species,
strain and sex differences need therefore to be considered as
factors that influence the ability of WAS to affect visceral
sensitivity. In female Wistar rats, the failure of repeated WAS
to cause visceral hyperalgesia is associated with a failure to
activate the hypothalamic-pituitary-adrenal axis (Deiteren et al.,
2014). In male Long-Evans rats, acute exposure to WAS induces
visceral hypersensitivity only in maternally separated animals,
an effect that seems to involve central, but not peripheral,
CRF receptors (Schwetz et al., 2005; van den Wijngaard et al.,
2012). The potential influence of sex was examined in Wistar
rats in which Larauche et al. (2012) observed visceral analgesia
immediately after acute WAS exposure, an effect that depended
on opioid signaling in female, but not male, animals. Apart from
species, strain and sex, factors such as the method used to record
visceral sensitivity, housing condition and animal handling
may in addition affect WAS-associated changes in visceral
sensitivity.
The mechanical hyperalgesia in the abdominal skin of DSS-
treated mice and the mechanical and thermal hyperalgesia in the
plantar skin of DSS- and WAS-treated mice failed to develop
when the animals were treated withWAS+DSS. This observation
suggests that DSS- and WAS-induced sensitization processes
involve different signaling mechanisms that interact with each
other in a negative way. In keeping with this contention, WAS
and WAS+DSS, but not DSS, caused MAPK phosphorylation
in the brain while c-Fos expression was stimulated by WAS
and DSS, but not WAS+DSS. These results suggest that DSS
and WAS activate different signal transduction pathways that
converge on c-Fos but inhibit each other in inducing c-Fos when
activated in parallel.
The ability of WAS and DSS to cause MAPK and/or c-
Fos activation is most probably of relevance to central pain
sensitization. This conclusion is backed by the findings that
the mechanical and thermal hyperalgesia in the abdominal or
plantar skin of DSS- or WAS-treated mice as well as the DSS-
and WAS-induced c-Fos expression in the CNS disappeared
when the animals were treated with WAS+DSS. Importantly,
MAPK phosphorylation and c-Fos induction were altered in
the absence of any acute intervention and thus may have a
bearing on WAS- and DSS-evoked alterations of spontaneous
behavior.
Colitis and WAS Alter Cerebral Processing of
Acute Visceral Pain in a Differential Manner
Apart from alterations of spontaneous behavior and CNS
signaling, WAS and DSS modified the cerebral responses to an
acute visceral pain stimulus, intrarectal AITC. This chemical
stimulus is known to elicit pain and activate p42/44 MAPK
and c-Fos in the lumbosacral spinal cord within 1 h after
administration (Galan et al., 2003; Mitrovic et al., 2010). Here
we found that intrarectal AITC also activated p42/44 MAPK and
c-Fos in all brain regions examined. These signaling reactions
were associated with prolonged freezing (Laird et al., 2001) and
decreased activity, thought to be a readout of visceral pain in
mice (Schwartz et al., 2013). We hypothesize that MAPK and
c-Fos activation in the CNS mirrors the sensory, emotional and
autonomic processing of a visceral pain stimulus. This contention
is affirmed by the ability of morphine to inhibit both AITC-
evoked aversive behavior and molecular signaling in the CNS.
Experiments involving DSS and WAS enabled us to compare
the cerebral processing of an acute visceral pain stimulus
under conditions of hyperalgesia with and without colonic
inflammation. While DSS and WAS modified molecular brain
signaling, DSS reduced pain-related freezing (a DSS effect).
WAS and DSS likewise failed to modify the visceromotor pain
response to colorectal distention in mice (Larsson et al., 2009).
In contrast, AITC-associated locomotion and c-Fos expression
in the hypothalamus and amygdala were enhanced by WAS
whereas c-Fos expression in the thalamus was diminished. A
similar region-specific effect emerges from functional brain
mapping studies in rats exposed to WAS (Wang et al., 2013)
and in irritable bowel syndrome patients (Tillisch et al., 2011),
which points to exaggerated emotional regulation of distention-
evoked colorectal pain. Unlike WAS, DSS blunted the AITC-
evoked phosphorylation of p42/44 MAPK in the absence of
any major effect on c-Fos expression and inhibited the freezing
reaction to AITC. We conclude that DSS-induced colitis leads
to inhibition of cerebral MAPK signaling which is unrelated to
c-Fos expression but linked to pain-related behaviors such as
freezing. This contention conforms with the ability of MAPK
inhibitors to prevent visceral pain behavior (Matsuoka and Yang,
2012; Galan-Arriero et al., 2014) and re-emphasizes that MAPK
activation rather than c-Fos expression is relevant to nociception-
related behavior.
A differential engagement of MAPK and c-Fos signaling
in visceral pain behavior is further corroborated by the effect
of combined WAS+DSS treatment which blunts the freezing
reaction to intrarectal AITC (a DSS effect), prolongs the
locomotor reaction (a WAS effect) and causes distinct changes
in molecular CNS signaling. While the inhibitory effect of DSS
on cerebral MAPK phosphorylation was neutralized by WAS,
combined WAS+DSS treatment inhibited AITC-evoked c-Fos
expression in all CNS regions examined. These observations
indicate that experimental colitis and repeated WAS impact on
different signaling pathways in brain areas relevant to visceral
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pain processing. They also show that stress can counteract the
molecular manifestations of DSS-induced colitis in the brain,
which could explain why repeated WAS prevents the effect of
DSS to enhance anxiety and reduce social interaction (Hassan
et al., 2014).
The Effect of Morphine Indicates that
AITC-evoked Changes in p42/44 MAPK and
c-Fos Activation are Related to Nociception
The ability of morphine to reduce the effect of intrarectal
AITC to evoke freezing, MAPK phosphorylation and c-Fos
expression in the CNS in control mice indicates that these
responses involve opioid-sensitive neural pathways and reflect
manifestations of visceral nociception. The effect of AITC
to inhibit MAPK phosphorylation in the hypothalamus and
amygdala was relatively resistant to inhibition by morphine. It
is unlikely that this finding is related to the action of morphine
to stimulate locomotion and induce the Straub phenomenon
because morphine blunted the AITC-evoked c-Fos expression
in all CNS areas of all treatment groups. These observations
reaffirm the contention that MAPK and c-Fos signaling make
differential contributions to visceral pain processing in the CNS.
As previously proposed (Mitrovic et al., 2010), the site of action
of morphine is thought to be within the CNS because the colitis
parameters did not differ between the different treatment groups.
Conclusions
This study provides new perspectives on the cerebral processing
of visceral pain and the differential impact of colitis and
psychological stress on pain-related behavior and cerebral p42/44
MAPK and c-Fos activation. DSS and WAS act on different
signaling pathways that converge on c-Fos in a stimulatory
or inhibitory fashion, modifying spontaneous behavior and
the behavioral and molecular responses to an acute visceral
pain stimulus in a differential manner. The involvement of
p42/44 MAPK and c-Fos in different aspects of visceral
pain emphasizes the need for investigating the molecular
and behavioral manifestations of pain in parallel in order
to understand the sensory and emotional processing of a
visceral pain stimulus. Further work is required to define
the precise relationship between cerebral MAPK and c-Fos
signaling and distinct behavioral manifestations of visceral
pain.
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